NASDAQ · Key Statistics

CollPlant Biotechnologies Ltd (OPHI) P/E Ratio, ROE & Key Statistics

$3.68 NASDAQ: OPHI Market Cap $6.96M

Data as of Nov 16, 2026 (intraday, delayed) · Source: Financial Modeling Prep (methodology)

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for CollPlant Biotechnologies Ltd (OPHI), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Per share and size

MetricValue
Market capitalisationShare price times shares outstanding.$6.96M

CollPlant Biotechnologies Ltd (OPHI) statistics — frequently asked questions

How much debt does CollPlant Biotechnologies Ltd carry?

CollPlant Biotechnologies Ltd (OPHI) has a debt-to-equity ratio of 0.00, which compares total borrowings with shareholders' equity.

P/E and ROE of other Medical - Specialties stocks

ALC P/E 54.50STE P/E 30.38MLAB P/E 116.10QDEL ROE -20.13%MOBI key statisticsSI ROE -25.67%MASS ROE -17.42%ANIK ROE -1.28%APYX ROE -70.78%SKIN ROE -32.09%All Healthcare stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.